Donal OConnor - Perrigo Company Independent Director

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:3em;padding-top: 40px;;'>PRG</div>
PRGO -- USA Stock  

Last Earning Anouncement Date: December 31, 2015  

Mr. Donal OConnor is Independent Director of the Company. previously a director of Elan Corporationrationration, plc from May 2008 until Perrigos acquisition of Elan in December 2013. He was previously the senior partner of PwC in Ireland from 1995 until 2007. He was also a member of PwC Global board from 2003 to 2008 and was a former chairman of the PwC Eurofirms board. From December 2008 to May 2012, Mr. OConnor served as a director for Readymix plc, an Irish concrete manufacturer and supplier. From December 2008 to June 2010, Mr. OConnor served as the government appointed Chairman of Anglo Irish Bank plc. From July 2017 to July 2018, Mr. OConnor served as a director of Malin Corporationrationration. Since October 2015, Mr. OConnor has served as a director of Theravance Biopharma, Inc. Mr. OConnor also holds directorships on a number of private Irish company boards.
Age: 67  Director Since 2014      
353 1 709 4000  http://www.perrigo.com

Management Efficiency

The company has return on total asset (ROA) of 2.19 % which means that it generated profit of $2.19 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 4.32 % meaning that it created $4.32 on every $100 dollars invested by stockholders.
The company currently holds 3.5 B in liabilities with Debt to Equity (D/E) ratio of 60.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 2.03 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives


Yingqi XiaOrigin Agritech Limited
James KangOrigin Agritech Limited
Omkar GoswamiDr Reddys Laboratories Ltd
Louise ParentZoetis
Larry CordellOrigin Agritech Limited
William YoungVertex Pharmaceuticals Incorpor
Ashok GangulyDr Reddys Laboratories Ltd
Margaret McGlynnVertex Pharmaceuticals Incorpor
Min TangOrigin Agritech Limited
Arthur RyanRegeneron Pharmaceuticals
Gregory NordenZoetis
Bruce SachsVertex Pharmaceuticals Incorpor
David AltshulerVertex Pharmaceuticals Incorpor
Sridar IyengarDr Reddys Laboratories Ltd
Bharat DoshiDr Reddys Laboratories Ltd
Ravi BhoothalingamDr Reddys Laboratories Ltd
Christine PoonRegeneron Pharmaceuticals
Alfred GilmanRegeneron Pharmaceuticals
Fei WangOrigin Agritech Limited
Anupam PuriDr Reddys Laboratories Ltd
Bruce CarterDr Reddys Laboratories Ltd

Company Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company Plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, PresidentView
Gary Cohen, Independent DirectorView
Arthur Shannon, IR Contact OfficerView
Ronald Winowiecki, Acting CFOView
Svend Andersen, Executive Vice President and President - Consumer Healthcare InternationalView
Judy Brown, CFO and Executive VPView
Laurie Brlas, Independent DirectorView
Donal OConnor, Independent DirectorView
James Michaud, Chief Human Resource Officer, Executive Vice PresidentView
Louis Yu, Executive Vice President - Global QualityView
John Wesolowski, Executive Vice President and Presidentident - RXView
Theodore Samuelsto, Independent DirectorView
Scott Jamison, Executive Vice President General Manager - NutritionalsView
Ellen Hoffing, Independent DirectorView
Marc Coucke, Executive Vice President General Manager - Omega Pharma BusinessView
Adriana Karaboutis, Independent DirectorView
Michael Jandernoa, Independent DirectorView
Paul Weninger, Executive Vice President - Global Quality OperationsView
Thomas Farrington, Senior Vice President CIOView
Herman Morris, Independent DirectorView
Jeffrey Needham, Executive Vice President General Manager - Consumer HealthcareView
Todd Kingma, Executive VP, General Counsel and SecretaryView
Rolf Classon, Independent DirectorView
Raymond Silcock, CFOView
Shlomo Yanai, Independent Director NomineeView
Jatin Shah, Senior Vice President Chief Scientific OfficerView
Michael Stewart, Senior Vice President - Global Human ResourcesView
Jeffrey Kindler, Independent DirectorView
Jacqualyn Fouse, Independent DirectorView
Grainne Quinn, Executive Vice President Chief Medical OfficerView
Theodore Samuels, Independent DirectorView
Geoffrey Parker, Independent DirectorView
Murray Kessler, President CEO, DirectorView
Sharon Kochan, Executive VP and General Manager of InternationalView
Gary Kunkle, Lead Independent DirectorView
Joseph Papa, Chairman and CEOView
Marry Brlas, Independent Chairman of the BoardView
Bradley Alford, Independent DirectorView
Jeffrey Smith, Independent DirectorView
Bradley Joseph, IR Contact OfficerView
James Dillard, Executive Vice President Chief Scientific OfficerView
Douglas Boothe, Executive Vice President General Manager - Rx PharmaceuticalsView
Ronald Janish, Executive Vice President - Global Operations and Supply ChainView
Uwe Rohrhoff, President CEO, DirectorView

Stock Performance Indicators

Did you try this?

Run Stock Screener Now


Stock Screener

Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
All  Next Launch Module

Currently Active Assets on Macroaxis

Purchased over 70 shares of
a day ago
Traded for 36.66
Purchased over 30 shares of
a day ago
Traded for 78.79
Purchased few shares of
a day ago
Traded for 210.29
Purchased few shares of
a day ago
Traded for 1520.74
Purchased over 300 shares of
a day ago
Traded for 52.74
Please check Your Equity Center. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.